Biological treatment systems engineered for pharmaceutical wastewater with elevated BOD and COD from fermentation and synthesis operations.
Wastewater treatment for pharmaceutical formulation plants. Handle excipients, cleaning agents and product residues.
Treat biopharmaceutical wastewater from fermentation and cell culture.
GMP-compliant wastewater treatment for pharmaceutical facilities.
Wastewater treatment for active pharmaceutical ingredient manufacturing.
Pharmaceutical manufacturing generates wastewater with high BOD and COD from fermentation broths, synthesis reactions and equipment cleaning.
Every system is designed for your specific wastewater characteristics, flow profile, and effluent targets. No off-the-shelf assumptions — just validated process engineering.
Equipment selected from manufacturers with proven field performance in similar applications. Duty/standby arrangements and robust construction minimise unplanned downtime.
Design targets are set at 50-70% of consent limits, providing a safety margin for process variation. Continuous monitoring and automated reporting demonstrate compliance.
Intuitive controls, clear instrumentation, and accessible maintenance points reduce training requirements. Standard operating procedures written in plain language.
Direct access to our process engineers for operational advice, troubleshooting, and optimisation. Remote diagnostics and rapid on-site response keep your plant running.
Materials certified to EN 10204 3.1, welding procedures qualified to ISO 9606, and pressure testing to 1.5x design pressure. Full traceability from mill to commissioning.
Our pharmaceutical advanced biological treatment systems include MBBR and SBR processes with specialised microbial cultu
Comprehensive analysis of wastewater volume, quality, temperature, and variability informs process selection and equipment sizing for optimal performance.
Treatment train selected from screening, DAF, biological, filtration, and disinfection options based on effluent targets, footprint, and Capital expenditure constraints.
Materials, pumps, blowers, and instruments specified for the specific duty conditions, chemical environment, and operational maintenance capabilities.
PLC-based control with online monitoring automates chemical dosing, aeration, and sludge withdrawal. Remote access provides 24/7 oversight.
Site acceptance testing verifies mechanical, electrical, and process performance. Operator training ensures confident day-to-day management.
Contractual effluent targets with financial backing demonstrate our confidence. Monthly reporting proves continuous compliance for regulators and stakeholders.
Treatment systems consistently achieve discharge compliance for organic parameters while handling the variable loads fro
Achieves 85-98% COD reduction depending on process selection and influent characteristics. Anaerobic pre-treatment followed by aerobic polishing delivers the highest removal rates.
Total suspended solids reduced to below 10-30 mg/L through coagulation, flocculation, and physical separation. Lamella and DAF clarification provide consistent solids removal.
Fat, oil, and grease reduced to below 5-15 mg/L using CPI separators, DAF, and biological degradation. Pre-treatment protects downstream processes from fouling.
Ammonia-N below 5-10 mg/L and total phosphorus below 1-2 mg/L achieved through biological nitrification-denitrification and chemical precipitation with ferric salts.
Effluent pH maintained within 6.5-8.5 through automated acid/alkali dosing with inline probe control. Buffer tanks prevent pH shock to receiving waters.
Systems designed for peak flows of 1.5-3x average daily flow with hydraulic capacity to handle diurnal variation without bypass or loss of treatment quality.
Ozonation and O3/UV advanced oxidation for Colour removal, odour control, and micropollutant destruction in industrial wastewater.
View PageDirectory of international wastewater treatment regulations and equipment compliance standards Organised by country and region.
View PageWastewater treatment for active pharmaceutical ingredient manufacturing.
View PagePharmaceutical manufacturing generates complex wastewaters containing active pharmaceutical ingredients (APIs), solvents, high organic loads, and variable pH. Our treatment trains combine advanced oxidation, specialised biological degradation, and precision separation to achieve discharge consent while protecting downstream municipal treatment works from potent compound disruption.
Advanced oxidation and photo-Fenton processes mineralise recalcitrant pharmaceutical compounds.
Vacuum distillation and membrane separation recover valuable solvents for re-use or resale.
Specialised biomass acclimated to pharmaceutical wastewaters resists shock loading.
Full IQ/OQ/PQ documentation packages for validated manufacturing environments.
| COD Range | 2,000 – 50,000 mg/L |
| BOD/COD Ratio | 0.3 – 0.6 (biodegradable fraction) |
| pH Variation | 2.0 – 12.0 (acid/alkali cleaning cycles) |
| TDS Loading | Up to 80,000 mg/L (brine and buffer salts) |
| Temperature | 15 – 45°C (process dependent) |
| HRT Bioreactor | 24 – 72 hours (extended for recalcitrant COD) |
| Sludge Yield | 0.4 – 0.8 kg DS/kg COD removed |
| Materials | SS316L, duplex, PTFE-lined (solvent resistance) |
Environmental risk assessment and ERA compliance for API manufacturing discharge.
Qualified equipment and validated cleaning procedures for multiproduct facilities.
Water quality meets EP, USP, and JP requirements for purified and Water for Injection.
Our experts can design a system tailored to your specific requirements.
Our expertise spans multiple industries with sector-specific water treatment solutions.